CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 81 filers reported holding CONCERT PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $126,000 | -58.7% | 25,324 | +5.0% | 0.00% | -50.0% |
Q4 2020 | $305,000 | +60.5% | 24,113 | +24.5% | 0.00% | +100.0% |
Q3 2020 | $190,000 | -35.4% | 19,362 | -34.4% | 0.00% | -50.0% |
Q2 2020 | $294,000 | -41.2% | 29,525 | -47.8% | 0.00% | -50.0% |
Q1 2020 | $500,000 | -76.2% | 56,564 | -75.1% | 0.00% | -60.0% |
Q4 2019 | $2,098,000 | +78.2% | 227,400 | +13.6% | 0.01% | +100.0% |
Q3 2019 | $1,177,000 | -58.0% | 200,209 | -14.2% | 0.01% | -61.5% |
Q2 2019 | $2,800,000 | +75.4% | 233,344 | +76.5% | 0.01% | +85.7% |
Q1 2019 | $1,596,000 | +3.0% | 132,192 | +7.0% | 0.01% | 0.0% |
Q4 2018 | $1,550,000 | -31.7% | 123,505 | -19.2% | 0.01% | -22.2% |
Q3 2018 | $2,268,000 | -42.4% | 152,818 | -34.7% | 0.01% | -43.8% |
Q2 2018 | $3,940,000 | +44.3% | 234,106 | +96.4% | 0.02% | +45.5% |
Q1 2018 | $2,730,000 | +183.5% | 119,201 | +220.3% | 0.01% | +175.0% |
Q4 2017 | $963,000 | +1560.3% | 37,220 | +1105.3% | 0.00% | – |
Q3 2015 | $58,000 | -79.5% | 3,088 | -83.7% | 0.00% | -100.0% |
Q2 2015 | $283,000 | -42.8% | 19,003 | -41.8% | 0.00% | -66.7% |
Q1 2015 | $495,000 | – | 32,658 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
L1 Capital Pty Ltd | 968,198 | $9,634,000 | 3.29% |
INGALLS & SNYDER LLC | 1,382,048 | $13,751,000 | 0.79% |
SPHERA FUNDS MANAGEMENT LTD. | 700,710 | $6,972,000 | 0.66% |
Alambic Investment Management, L.P. | 17,900 | $178,000 | 0.45% |
RA Capital Management | 1,858,474 | $18,492,000 | 0.36% |
Perceptive Advisors | 2,150,641 | $21,398,000 | 0.35% |
Eversept Partners, LP | 232,983 | $2,318,181 | 0.32% |
GSA CAPITAL PARTNERS LLP | 17,351 | $173,000 | 0.10% |
Alyeska Investment Group, L.P. | 502,783 | $5,003,000 | 0.08% |
KENNEDY CAPITAL MANAGEMENT LLC | 263,958 | $2,626,000 | 0.08% |